President Donald Trump hinted at the possibility of the United States rejoining the World Health Organization (WHO), days after initiating the country’s withdrawal. Speaking at a rally in Las Vegas, Trump stated, “Maybe we would consider doing it again... They would have to clean it up.” The U.S. is set to leave the WHO on January 22, 2026, following Trump’s decision after being sworn in for a second term.
Trump criticized the WHO’s handling of the COVID-19 pandemic and other global health crises, expressing frustration that the U.S. contributes significantly more funding than China despite its smaller population. The U.S. currently accounts for approximately 18% of the WHO’s $6.8 billion budget for 2024-2025, making it the organization’s largest financial supporter.
In his speech, Trump also discussed expanding economic ties with Saudi Arabia. He shared that Crown Prince Mohammed bin Salman recently pledged $600 billion in investments and trade over the next four years. Trump said he aims to increase this figure to $1 trillion to boost the U.S. economy.
Trump’s remarks highlight his focus on prioritizing U.S. interests in international organizations and partnerships. Whether the U.S. returns to the WHO will likely depend on reforms addressing Trump’s concerns over funding disparities and operational efficiency.
These developments come as Trump seeks to reshape global alliances while emphasizing stronger investment ties with key partners like Saudi Arabia.


Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown
Cuba Reaffirms Anti-Drug Cooperation as Tensions Rise in the Caribbean
Michael Dell Pledges $6.25 Billion to Boost Children’s Investment Accounts Under Trump Initiative
Taiwan Opposition Criticizes Plan to Block Chinese App Rednote Over Security Concerns
UN Chief Says Gaza Operation “Fundamentally Wrong” as Concerns Over War Crimes Grow
U.S. Justice Department Orders Intensified Probe Into Antifa and Domestic Extremist Groups
Novo Nordisk Appoints Greg Miley to Lead Corporate Affairs Amid U.S. Drug Pricing Pressure
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure
FDA Pilot Program Eases Rules for Nicotine Pouch Makers
Taiwan Signals Openness to Renew Ties with Honduras as Election Unfolds
Major Drugmakers Slash U.S. Prices and Sell Directly to Patients Amid Trump’s Push for Affordable Medicines
Honduras Election Turmoil Deepens as Nasralla Alleges Fraud in Tight Presidential Race
New Orleans Immigration Crackdown Sparks Fear as Federal Arrests Intensify 



